3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
11
Phase 2
10
Phase 3
3
Phase 4
2
Phase EARLY_PHASE1
1
Phase 1
1
Status
Completed
29
Recruiting
5
Terminated
4
Withdrawn
1
Unknown
1
Suspended
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Neoplasms
87
Carcinoma, Non-Small-Cell Lung
76
Breast Neoplasms
73
Recurrence
65
Colorectal Neoplasms
63
Pancreatic Neoplasms
60
Melanoma
58
Advanced Solid Tumor
57
Multiple Myeloma
56
Carcinoma, Hepatocellular
56
Lymphoma
53
Leukemia, Myeloid, Acute
53
Advanced Solid Tumors
53
Neoplasm Metastasis
51
Stomach Neoplasms
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
44
Lymphoma, B-Cell
40
Solid Tumor
39
Lymphoma, Non-Hodgkin
39
Ovarian Neoplasms
38
Lung Neoplasms
36
Glioblastoma
35
Prostatic Neoplasms
34
Leukemia
28
Head and Neck Neoplasms
27
Leukemia, Lymphocytic, Chronic, B-Cell
26
Uterine Cervical Neoplasms
25
Burkitt Lymphoma
24
Esophageal Neoplasms
23
Urinary Bladder Neoplasms
20
Interventions
TH 302
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Unknown
×
Gastrointestinal Stromal Tumors
×
Clear all
NCT01381822
2014-04-21
TH-CR-410
Threshold Pharmaceuticals
Phase 1
Unknown
58 enrolled